期刊文献+

加校正因子的主成分自身对照法测定盐酸普拉克索的有关物质 被引量:7

Determination of Related Substances of Pramipexole Hydrochloride by Correction Factor
原文传递
导出
摘要 目的建立盐酸普拉克索原料药中有关物质的含量测定方法。方法采用HPLC建立盐酸普拉克索及其杂质A、B、C、E的线性方程,以斜率计算杂质相对于主成分的校正因子,并用该校正因子测定有关物质的含量。通过方法学考察证明此方法的可行性。结果盐酸普拉克索杂质A、B、C、E的校正因子分别为0.642,0.999,0.796,0.999;相对保留时间为0.703,1.512,1.733,0.522;方法学考察验证该方法符合要求;3批样品中杂质A、B、E均未检出,杂质C的含量分别为0.013%,0.013%,0.012%。结论加校正因子的主成分自身对照法能够准确测定盐酸普拉克索原料药中有关物质的含量。 OBJECTIVE To develop a method for determing the content of related substances of hydrochloric acid pramipexol. METHODS HPLC was used to establish the linear equation of pramipexole hydrochloride and its impurity A, B, C and E. The slope of linear equation was used to determine the correction factor of impurity A, B, C and E, and the validation of the analytical method was determined. RESULTS The correction factors of pramipexole hydrochloride impurity A, B, C and E were 0.642, 0.999, 0.796 and 0.642, and the relative retention time was 0.703, 1.512, 1.733, 1.512. Impurity A, B and E were not detected in 3 batches of samples, and the content of impurity C was respectively 0.013%, 0.013% and 0.012%. CONCLUSIONS The correction factor method is viable to determine the content of related substances of pramipexole hydrochloride dihydrate.
出处 《中国现代应用药学》 CAS CSCD 2015年第11期1366-1370,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 盐酸普拉克索 高效液相色谱法 有关物质 校正因子 hydrochloric acid pramipexole HPLC related substances correction factor
作者简介 李晶,女,硕士生Tel:13512119482E—mail:1007000516@qq.com 通信作者:石森林,男,博士,教授,博导Tel:(0571)86613524E-mail:pjstone@163.com
  • 相关文献

参考文献9

二级参考文献35

  • 1张惠琴,胡雄伟.血管紧张素转换酶抑制剂抗高血压的发展与研究[J].医学理论与实践,2004,17(6):647-649. 被引量:8
  • 2裴晓丽,刘明月,张小山,贾海英,李灵芝,白晓军.HPLC测定雷贝拉唑钠原料的含量及有关物质[J].中国药学杂志,2004,39(8):631-631. 被引量:9
  • 3何解生.抗溃疡病药雷贝拉唑的药理与临床[J].实用药物与临床,2005,8(1):42-43. 被引量:20
  • 4何莉,蔡溱.赖诺普利的临床应用新进展[J].药学服务与研究,2006,6(6):450-453. 被引量:11
  • 5P Sreenivasa Rao,Uttam Kumar Ray,P Badarinadh Gupta,et al.Identification,isolation and characterization of new impurity in rabeprazole sodium[J].J Pharm Biom Analysis,2010,52(4):620.
  • 6中国药典.二部[S].2010:附录29.
  • 7European Pharmacopoeia Convention. European Phar-macopoeia 7th Edition[ M]. Strasbourg: European Di-rectorate for the Quality of Medicines, 2010: 1951 -1953.
  • 8European Directorate for the Quality of Medicines &Health Care. Technical Guide for the Elaboration ofMonographs. 6th Edition [ M]. Strasbourg: EuropeanDirectorate for the Quality of Medicines & HealthCare,2011:66.
  • 9张哲峰.HPLC法校正因子研究中的几个问题[OL].(20111207) [20130113]. http://www. cde. org. cn/dzkw. do. method = largePage&id = 312552.
  • 10国家食品药品监督管理局.赖诺普利氢氯噻嗪片标准[S].YBH01852008.

共引文献20

同被引文献103

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部